
Ornid500 mg
Drug International Ltd.
Ornidazole is a nitroimidazole derivative with antiprotozoal and antibacterial (anti-anaerobic) activity.
Ornidazole is a nitroimidazole derivative with antiprotozoal and antibacterial (anti-anaerobic) activity. Its uses can be classified by strength of evidence as follows:
Ornidazole is not approved or marketed in the United States, so it does not carry a US FDA label; the uses above reflect established international prescribing practice and guideline-supported indications, including use in South Asian countries such as Bangladesh.
Dosage of Ornidazole should always be individualised by the prescribing physician based on the indication, severity of infection, patient age, weight, and renal/hepatic function. The following is general dosing guidance:
| Indication | Adult Dose | Paediatric Dose | Typical Duration |
|---|---|---|---|
| Intestinal amoebiasis (amoebic dysentery) | 500 mg twice daily | 25-40 mg/kg/day in divided doses | 5-7 days |
| Amoebic liver abscess | 500 mg twice daily | 25-40 mg/kg/day in divided doses | 5-10 days |
| Giardiasis | Single dose of 1.5 g, or 500 mg twice daily | 40 mg/kg as a single dose (max as per adult dose) | 1-2 days |
| Trichomoniasis / Bacterial vaginosis | Single dose of 1.5 g, or 500 mg twice daily; treat sexual partner concurrently | Not routinely indicated | 1-5 days |
| Anaerobic bacterial infections | 500-1000 mg every 12 hours (oral or IV), usually with an agent active against aerobes | Individualised by weight; specialist guidance advised | 5-10 days depending on response |
| Surgical prophylaxis (anaerobic coverage) | 500-1000 mg IV as a single dose, 30-60 minutes before surgery | Not routinely used | Single dose (occasionally 1-2 further doses post-op) |
Antimicrobial stewardship: Take Ornidazole exactly as prescribed by your physician; do not stop, extend, skip doses, or share this medicine with others without medical advice, even if symptoms improve before the course is finished.
See Precautions & Warnings for hepatic dose adjustment, and Use in Special Populations for renal impairment and elderly dosing considerations.
Most adverse effects of Ornidazole are mild and transient. Reported side effects include:
Seek medical attention promptly if severe rash, breathing difficulty, unusual bleeding/bruising, or persistent numbness/tingling occurs.
Ornidazole is contraindicated in the following situations:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.